NASDAQ:NAMS | EBITDA | NewAmsterdam Pharma Co N.V.

Complete source-backed ebitda history.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$58.36M
2025-12-31-$65.92M
2025-03-31-$68.87M
2024-12-31-$43.18M
2024-03-31-$55.47M
2023-12-31-$51.06M
2023-03-31-$39.84M

Annual EBITDA

DateEBITDA
2025-12-31-$225.46M
2024-12-31-$176.18M
2023-12-31-$182.92M
2022-12-31-$3.55M
2021-12-31-$34.97M